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Abstract 
Porous biomedical implants hold great potentials in preventing stress shielding while 
improving bone osseointegration and regeneration. In this paper, a novel approach is 
introduced to control the porosity of 316L stainless steel implants by using canister-free hot 
isostatic pressing (CF-HIPing). The proposed approach uses cold isostatic pressing (CIPing) to 
generate powder compacts with various particle size, followed by CF-HIPing. 316L stainless 
steel samples with controlled porosity, mechanical and biological properties were successfully 
achieved. The results showed a significant increase in the samples porosity with increasing the 
powder size. Porous structures with strength of 108-360 MPa, Vickers hardness of 25-49 HV 
and elastic modulus between 17-50 GPa were produced using a particle size range of 5-50 µm. 
The effect of samples with various porosity on in vitro response of mouse pre-osteoblastic in 
terms of toxicity and proliferation was studied. All samples showed that they had a minimal 
toxic effect on the osteoblasts. Samples with low porosity, prepared using a particle size of 5 
µm, is believed to hinder the transport of nutrients and oxygen to the cells hence had lower 
proliferation. In addition, samples prepared using a particle size range of 16-50 µm were 
associated with an increased proliferation and are therefore expected to improve the rate of 
bone osseointegration. 
Keywords: Porous implants; Stainless Steels; Hot Isostatic Pressing; Cold Isostatic Pressing. 
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1. Introduction  
The surge in demand for biomedical implants is fuelled by many factors such as the increase of 
the global population, implementation of better healthcare and ageing. With the rapid increase of 
the human population over the past decade, technologies to enhance healthcare quality have 
become abundant, particularly for individuals who suffer from chronic illness or traumatic 
injuries 1. Osteoporosis is one of the most common diseases encountered in the elderly. It is a 
health condition associated with bone structural deterioration, and porous bone which increases 
the risk of fracture 2. In the UK, around 3 million people suffer from osteoporosis. Despite the 
advancements in the screening tools and the early diagnosis of osteoporosis, bone fracture is 
common amongst geriatrics and affects 20% of males and 50% of females over the age of 50 3. 
Over the years, the demand for biomedical implants has increased, with global sales estimation 
of over $116 billion by 2022 with annual growth rate of 7.1% from 2016 to 2022. The 
orthopaedic implants sector is considered the highest revenue-generating segment in the 
biomedical implant market due to various reasons including aging, stressful lifestyle, unhealthy 
eating habits, and most importantly the development of advanced biomedical implants 4. 
Surgeries involving orthopaedic implants have been well established for many years now. They 
are implemented to help people who suffer from joint and bone diseases. Nonetheless, around 
10% of orthopaedic implant surgeries fail 5; mainly because of fibrous encapsulation, infections 
and stress shielding caused by the elastic modulus mismatch between the bone and the implant 6.  
In response to stress shielding, the osteoclast activity increases causing a reduction in the bone 
density and eventually is resorbed. Hence, metal materials with Young’s modulus similar to that 
of the bone are preferred for manufacturing biomedical implants. Other properties such as 
corrosion, density, strength, radiolucency, thermal conductivity, melting point, and malleability 
are also important in selecting the implants’ materials 7, 8. 
Metals and alloys have superior structural and mechanical properties, nonetheless, the majority 
are susceptible to corrosion or biological reactions, leaving only a few suitable candidates for 
biomedical implants such as titanium and its alloys, cobalt-chromium alloys, ceramics, 
zirconium alloys and stainless steel 9-11. Stainless steel 316L, also known as surgical stainless 
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steel is the recommended grade for surgical device manufacture 12. It has excellent mechanical 
properties (strength and ductility), biocompatibility, pitting and crevice corrosion resistance due 
to the presence of chromium and molybdenum. Stainless steel 316L has an elastic modulus of 
193 GPa, which is 6- 20 times greater than human bone elastic modulus, making stainless steel 
316L implants susceptible to failure by stress shielding. Moreover, it decreases the interfacial 
bond between the solid implant and the surrounding tissues 13. Introducing porosity into metals 
and alloys can be used as an effective strategy to reduce their elastic modulus. As such, the 
development of porous implants could be an effective technique to address these concerns, by 
controlling the porosity content and hence the stiffness of the implant to match the bone’s 
stiffness 14-17. In addition, a porous biomedical implant allows an excellent environment for 
body fluids and drugs to flow effectively through the porous network. This therefore offers 
better opportunities for the body tissue to grow and enhance osseointegration and bone 
regeneration by providing a good interfacial bonding between the implant and bone 18-20.  
Recently, manufacturing processes of highly porous materials have gained much attention 
especially for biomedical applications. Powder metallurgy and sintering of compacted powders 
is one of the common approaches that have been used to fabricate porous parts 21, 22. Space 
holders or foaming agents have also been investigated for their potential ability to create porous 
materials 23, 24. Nonetheless, impurities and contaminations limit the use of this process for 
biomedical applications, where using materials with extra low interstitials is typically required. 
The most commonly used  methods to produce highly porous biomaterials are gas foaming, salt 
leaching, freeze-drying, and phase separation depending on the material used to manufacture the 
scaffold structure 25-27. Injection moulding combined with a space holder process was also 
investigated for the production of structures with highly porous parts. Injection moulding offers 
rapid and mass production with low labour cost and waste. However, the tooling cost and the 
design restrictions limit the use of this technique for biomedical applications. Another limitation 
is the high reactivity of metals during de-binding, resulting in production of parts with high 
interstitial content 28. Recently, developments in additive manufacturing have offered 
unprecedented opportunities for manufacturing structures to meet the high demands for 
biomedical implants 29, 30. However, limitations of AM processes, such as overhanging 
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structures, supporting structure removals, post processing techniques, materials sustainability, 
inspection, and quality control need to be addressed for future applications 31. 
Hot Isostatic Pressing (HIPing) is a heat treatment process where high pressures and high 
temperatures act simultaneously on metal or ceramic parts to eliminate porosity and achieve full 
density and isotropic properties 32, 33. HIP is considered  as a high performance and  viable 
option to conventional methods such as machining, casting and metal forming in different 
applications 34. HIP is currently used as a post process to further densify porous components or 
as a net shape process to consolidate powder. It is also used as a diffusion bonding technique for 
joining parts. It can bind to similar or different materials using the simultaneous effect of the 
isostatic gas pressure and high temperature 35. In a typical HIP process, a metal or a glass 
canister is being prepared with a cavity representing the design of the desired shape. The initial 
geometry of the canister has to be well designed to compensate the shrinkage during the process. 
The canister is subsequently filled with metal powder, packed using vibratory table to achieve 
powder with uniform density, outgassed for 24 hours, and sealed by hot crimping 36, 37. After 
HIPing the canister, chemical leaching or machining is employed to remove and achieve the 
HIPed Part. Currently, a plethora of research has been reported on HIP for aerospace and 
automotive applications while only a few reports explored HIP in biomedical applications 35. 
This could be attributed to the high cost associated with HIP compared to conventional 
techniques. Manufacturing and removal of the HIP sacrificial canisters are large contributors to 
the high cost of HIP parts and restricts their complexity. Haan et al. investigated the effect of 
HIP on the properties of additive manufacturing parts. It was reported that fatigue properties of 
selective laser melting cobalt-based implants were significantly enhanced by using HIP. 
Selective laser melting samples typically exhibit a significant amount of porosity and defects. 
Hence, applying HIP post process helps to eliminate porosity and improve the implant 
mechanical properties 38. HIP was also used to promote hydroxyapatite (HA) coatings by 
creating a strong bond on a titanium implant 39, 40. Furthermore, HIP was implemented for the 
densification of zirconia implants with improved fatigue properties 41.  
In this paper, the typical HIP process was modified by not using a canister for powder 
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capsulation. Hence, porosity was promoted and could potentially be used in low-stiffness 
implants. In addition, HIPing without a canister, a canister free HIPing (CF-HIP), can 
significantly reduce the overall cost of the process. Wet bag cold Isostatic Pressing (CIP) was 
used to prepare the stainless steel green parts by applying isostatic pressure on soft moulds filled 
with stainless steel powder. Afterwards, the compacted parts were subjected to HIPing without 
using a canister. Different particle sizes were used in the experimental work and the influence of 
the mean particle size on the properties of the HIPed samples were investigated. Because 
implants are designed to be in intimate contact with living cells and tissues, implants should 
improve bone regeneration. Therefore, biocompatibility characterisation was used to evaluate 
the cytotoxicity and to investigate the influence of the process on the growth and proliferation of 
the bone cells. 
2. Experimental  
2.1. Powder, CIP and CF-HIP 
Stainless steel 316L powder was supplied by Sandvik Osprey, UK. Four different particle sizes 
were investigated with mean particle sizes (D50) of 5, 10, 16 and 50 µm. Table 1 shows the 
composition of the supplied powder. The received powders were examined using Scanning 
Electron Microscopy (SEM) to assess their morphology. SEM images of the powders are shown 
in Figure 1. The figure shows that the majority of the particles have a spherical morphology in 
the various sizes, which helps produce a high packing density due to the ease of the powder 
flow. 
 
 
Table 1: Composition of the 316L powders 
Element Fe Cr Ni Mo Mn Others 
Percentage (%) Balance 16.5 10.5 2.1 1.5 0.9 
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Figure 1: SEM images of the stainless steel 316L powder with mean particle sizes of (a) 5 µm, 
(b) 10 µm, (c) 16 µm, (d) 50 µm. 
Wet bag CIPing was carried out to compact the four stainless steel powders. The reason for 
using CIP to compact the stainless steel 316L powder is that it does not need any additives to 
achieve uniform compacts. In order to prepare the samples, soft moulds made from 
Polydimethylsiloxane (PDMS) were first produced. Cylindrical-shaped cavities of different 
sizes were prepared to assess the mechanical and physical properties of the samples. PDMS 
prepolymer (Sylgard 184-Dow, Corning Corp.) consists of two parts (a base material and a 
curing agent). Glass or metal cylinders representing the samples dimensions were placed onto a 
plastic substrate. Next, the plastic substrate holding the cylinders was placed onto an aluminium 
container as shown in Figure 2a. The PDMS base material and the curing agent were mixed 
thoroughly using a mechanical stirrer with a weight ratio (base to curing agent) of 10:1. The mix 
was de-aired in a vacuum chamber to remove any trapped bubbles. After de-airing, the mixture 
was poured onto the mould and de-aired again. The mould was cured at 70 °C for 3 hours. After 
cooling, the cured soft mould was peeled off from the master mould as shown in Figure 2b. The 
prepared soft moulds shown in Figure 2c were filled with as-received powders using a vibratory 
table to achieve a uniform and good packing of the powder. Next, the soft moulds were sealed 
(a) (b) 
(c) (d) 
 50 µm 
 10 µm  10 µm 
 20 µm 
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using a PDMS lid and placed in a rubber bag.  The rubber bag was then placed inside the CIP 
cylinder and filled with water, prior to pressurising the cylinder to 60 MPa. The pressure was 
left to stabilize over 5 minutes before gradually releasing the valve. The rubber bag was then 
removed to extract the green compacts, see Figure 2d. The green CIPed compacts were 
subsequently HIPed using a canister-free method (i.e. without canister). This means that the 
CIPed samples were placed in the HIP cylinder, followed by increasing the temperature and the 
pressure according to the HIP cycle. The cycle involved simultaneous application of temperature 
and pressure to 920˚C and 103 MPa, respectively, followed by an isothermal dwell at 920˚C of 2 
hours, and finally furnace cooling to room temperature. 
 
Figure 2: (a) master mould, (b) soft moulds, (c) soft mould ready for CIP, (d) CIPed sample. 
 
2.2. Microstructural and Mechanical Characterisation  
The aim to use four particle sizes in the preparation of the HIPed samples is to investigate the 
effect of the particle size, hence porosity, on the microstructural, mechanical, and biological 
properties of the samples.  The powder apparent density was measured using the hall flowmeter 
funnel of free flowing powder following the guidelines of ASTM B212 42. On the other hand, 
density of the bulk CIPed compacts was measured using the mass to volume ratio. The mass was 
measured using an electronic balance supplied by Nimbus Precision while the volume of CIPed 
samples was calculated using 𝜋𝜋/4×𝐷𝐷2×ℎ where D and h are diameter and height, respectively. 
(a) (b) 
 20 mm  20 mm 
 10 mm  20 mm 
(d) (c) 
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The HIPed samples were ground, polished and cleaned using ultrasonic cleaning for 
microstructure characterization. A Hitachi TM3000 desktop Scanning Electron Microscope 
(SEM) and an optical microscope were used to characterize the porosity and the microstructure 
of the samples.  Micrographs from the HIPed samples were taken at several locations across the 
polished sample surface. Porosity size and distribution were achieved by quantitative imaging 
analysis (using ImageJ®) of the polished samples. A JEOL7000 SEM was used to investigate 
the influence of the particle size on the microstructure of the samples. In addition, the samples 
were scanned by using a Bruker Skyscan1172 micro-computer tomography (micro-CT), with a 
maximum X-ray energy of 80 kV, 8 W beam power, 570 ms exposure per projection, aluminium 
and copper filter, and 3.4 μm pixel size to check the level of porosity within the HIPed samples. 
The scanned data were reconstructed into a 3-dimensional volume using NRecon Software 
(Bruker) 43, producing images with a spatial resolution of ~5 µm. Following reconstruction, the 
image analysis and thresholding were performed by CTan module (Bruker). 3D visualisation of 
surface connected and enclosed porosity was performed over selected volume of interest using 
CTVol module (Bruker). For all four samples, region of interest was selected across 1000 slices 
placed in the middle of the longitudinal axis (y-axis) of the samples to create volume of interest. 
Micro-hardness measurements were performed on polished surfaces of the samples using an 
INDENTEC hardness tester with a Vickers pyramid indenter and a load of 10 kg. In addition, 
compression test samples were machined out from the HIPed parts (5 samples per condition), 
with a square cross section of 5 mm × 5 mm and a length of 10 mm. The testing was conducted 
using ESH Servo Hydraulic Machine, with a strain rate of 1 mm/min1. 
2.3. In vitro Biocompatibility  
2.3.1 Neutral Red Cytotoxicity Assay 
The four HIPed samples were machined to a disk shape with diameter of 5 mm and thickness of 
2 mm for the biocompatibility study. The Stainless steel 316L implants were cleaned using 
deionized water then soaked in absolute ethanol for 15 minutes. All implants were sterilized by 
exposing to ultraviolet light for 4 hours prior to the biological testing. The toxicity of the four 
implants was evaluated using mouse pre-osteoblastic cell line (MC3T3-E1; Preosteoblast; 
Mouse, ECACC). MC3T3 cells were cultured in Minimum Essential Medium α (Gibco™ MEM 
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α Nucleosides, No Ascorbic Acid Fisher Scientific ) supplemented with 10% Fetal Bovine 
Serum (Fisher Scientific), and penicillin-streptomycin (Penicillin-Streptomycin with 10,000 
units penicillin and 10 mg streptomycin per mL in 0.9% NaCl, (Sigma Aldrich UK). The cells 
were incubated at 37°C under 5% CO2. After reaching 80% confluence, cells were detached 
using Trypsin-EDTA solution 0.25%, (Sigma Aldrich UK), centrifuged, and re-suspended.  
For the neutral red assay, cells with passages between 6-10 were used.  After sterilization, the 
samples were carefully transferred into a 24-well plate containing 50,000 cells per well at a final 
volume of 400µL. MC3T3 cells in the presence of the implants were incubated for 24 hrs at 37 
°C with 5% CO2.  The growth media was then discarded carefully, to avoid disturbing or 
moving the insert, and the wells were washed twice with 300 μL of PBS followed by the 
addition of 200 μL of FBS free media containing neutral red (40 μg/mL). The plate was 
incubated at a temperature of 37 °C with 5% CO2 for 2 hrs after which the neutral red solution 
was discarded and the plate was washed with 300µL PBS. The plate was de-stained  using 200 
μL of the de-stain solution made up of 50% ethanol and 1% acetic acid, and then was placed in a 
plate shaker for 3 minutes. Finally, the optical density of the extracted dye was measured at 
540nm. The cell viability was calculated as mean OD value normalised to the negative control 
OD. Statistical significance was determined using one-way ANOVA of 3 independent 
experiments using GraphPad Prism (version 7.03). 
2.3.2 Real-Time Imaging  
The effect of the inserts on MC3T3 cells was observed in real time using an IncuCyte ZOOM® 
system. UV sterilised samples were carefully placed  into a 24 well plate. Into each well, 400 µL 
of MC3T3 cell suspension were added (50,000 cells/well). Then, the plate was transferred into 
the IncuCyte ZOOM® (Essen Bioscience, UK) accommodated inside a conventional cell 
incubator set at 37 °C with 5% CO2 . Phase contrast images from each well were captured over 
24 hours (at 2 hour intervals) using the 10x objective lens. The obtained images were analysed 
using IncyCyte Zoom 2015A GUI and the cell confluency vs time curve was constructed.  
Independent experiments were repeated 3 times.  
 
 
9 
 
3. Results and Discussions 
Effect of the particle size on the apparent, CIPed, HIPed densities is shown in Figure 3. As 
shown in the figure, the apparent densities of the powder are 41.4%, 47.2%, 50.3% and 53.5% 
for particle size 5, 10, 16 and 50 µm, respectively. It can be noted that, the apparent density of 
the powder increases as particle size increases. When the particle size increases, the friction and 
adhesion forces between particles reduces which lead to a better powder flowability and thus 
higher powder packing. On the other hand, densities of the CIPed compacts were enhanced after 
conducting CIP. Similar to the apparent density, the CIPed density of the samples increases as 
particle size increases. In particular, the densities of the CIPed compacts were 54.1%, 58.0%, 
60.2% and 63.1% for particle size 5, 10, 16 and 50 µm, respectively. Here, the CIPed density of 
the smallest particle size (5µm) increased by 12.7% while the CIPed density of the largest 
particle size (50µm) increased by 9.6%. In this case, when the particle size was decreased, the 
apparent density also decreased, and more space was available for particles rearrangement 
during CIPing. Hence, the applied pressure during CIP overcame the friction between particles 
and improved the density. In contrary to the apparent and CIPed densities, the density of the 
HIPed samples was decreased when the particle size increased. The density of the HIPed 
samples was 98.6%, 89%, 87.1% and 74.6% for particle size 5, 10, 16 and 50 µm, respectively. 
In order to understand the effect of the particle size on the densification of the samples, the 
microstructure of the CF-HIPed samples was characterised. Figure 4 shows the SEM 
micrographs of the microstructure of the CF-HIPed samples. The figure shows cross sections of 
the four developed 316L samples following CF-HIPing. As shown, different levels of 
densification are clearly visible which is believed to be caused by diffusion bonding of powder 
particles. When powder particle size decreases (Figure 4 a), a high bonding level between 
particles is achieved because of the short diffusion paths which leads to better densification. On 
the other hand, the presence of large open channels between coarse particles allows the gas 
pressure during CF-HIPing to penetrate and reduce diffusion bonding of powder particles, which 
leads to the presence of a large amount of porosity (Figure 4 d). The size of the channels 
between the particles generally increases with the increase in powder size. 
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Figure 3: Apparent, CIPped, HIPed densities of samples prepared using powders with mean 
particle size diameter of 5 µm, 10 µm, 16 µm, and 50 µm. 
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 Figure 4: SEM micrographs of the cross sections of porous 316L CF-HIPed samples of different 
particle sizes: (a) 5 µm, (b) 10 µm, (c) 16 µm and (d) 50 µm. 
 
To characterise the porosity of the CF-HIPed samples and the morphology of consolidation, 
micro-CT was performed to quantify the 3D variation in total porosity (surface connected and 
enclosed) using samples extracted from the core of the four particle size. In micro-CT, an open 
pore (surface connected) is defined as any pore found within a solid part or between solid 
objects, which has a connection in 3D to the pores outside the parts. Closed pore (enclosed) in 
3D defined as a pore (black) voxels that is fully enclosed on all sides in 3D by solid (white) 
voxels. Total porosity and pore size range have been distinguished, visualised and quantified 
(Table 2 and Figure 5). It is evident that there is an increase in the level of open porosity when 
the particle size of the starting material increased. The results also show that highly porous 
structures can be achieved when a coarse powder is used while almost fully dense structures are 
obtained when powders of fine size are used in CF-HIP approach.  
(a) (b) 
(d) (c) 
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Table 2: Quantitative analysis of total, surface connected and enclosed porosity and pore size 
range within the samples prepared with different particle size.  
  
 
Figure 5: Binarised view of CF-HIPed porosity for samples prepared using particle size of (a) 5 
µm, (b) 10 µm, (c) 16 µm, (d) 50 µm. 
It is well established that HIPing cannot consolidate surface connected pores. Therefore, it is 
useful to understand the CIP efficiency in sealing internal porosity by characterising the surface 
of the CF-HIPing samples. Figure 6 shows SEM images of the CF-HIPed samples focusing on 
the surface layer of the samples. As shown in Figure 6, in all samples, the surface of the CF-
HIPing samples shows a highly porous surface, with porosity approaching 30-50%. The 
thickness of the porous layer varied from ~80 µm, for samples prepared by 5 µm particle size, to 
~ 350 µm for those using 50 µm powder size. However, within the compact itself, the pore 
fraction increased to the ranges shown in Table 2. 
Particle size (µm) 5 10 16 50 
Total porosity (%) 1.4 11.0 12.9 25.4 
Surface connected porosity (%)  0.1  8.5 11.2 24.97 
Enclosed porosity (%) 1.3 2.7 1.9 0.40 
(a) (b) 
(c) (d) 
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Figure 6: SEM images of the surface layer of the 316 L HIPed samples synthesised  using a 
particle size of  a) 5 µm, b) 10 µm, c) 16 µm and d) 50 µm 
Figure 7, Figure 8 and Figure 9 show the effect of the porosity (in addition to the particle size) 
on compressive strength, Young’s modulus, and micro-hardness of the CF-HIPed samples. It 
also compares the measured properties with the typical properties of 316L solid samples 44. In 
general, all the aforementioned properties declined with the decrease of the porosity (increase in 
particle size). Samples with a particle size of 5 µm showed the lowest porosity of 1.4% and 
hence the highest combination of mechanical properties (360 MPa ultimate compressive 
strength, Young’s modulus of 50 GPa, and hardness of 49 HV). On the other hand, increasing 
the porosity content to 25.4% for particle size of 50 µm was accompanied by an obvious decline 
in these properties to reach 108 MPa, 17 GPa, and 25 HV, respectively. Additionally, the 
compressive strength of samples prepares using particle size of 50 µm was similar to the typical 
compressive strength of 316L samples 44. As described above the particle size of the powder has 
an impact on the morphology of the pores and the porosity fraction. In turn, these factors control 
the mechanical properties of the CF-HIPed materials. It could be clearly shown from Figure 3 
that the percentage porosity increases as the particle size increases which has a detrimental 
(a) 
 100 µm  100 µm 
(b) 
(c) (d) 
 100 µm  100 µm 
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influence on the mechanical properties of the material. The best approach is to optimise Young’s 
modulus-to-porosity % ratio is to match bone properties through using a particle size that could 
produce the desired values for the Young’s modulus and porosity %, see Figure 7 .  
Based upon the presented results, a particle size of 43 µm would be the optimum size for the 
desired application, as it would result in Young’s modulus of 22 GPa, which is in the range of 
those of human bone’s, and a porosity fraction of 22%. At these conditions, the compressive 
strength, ductility and hardness would be 147 MPa, 21.5% and 27 HV, respectively. As such, 
the mechanical properties of the CF-HIPed structures are likely to rely on the density of the 
consolidated component. 
 
Figure 7: Effect of porosity on the Young’s modulus of 316L CF-HIPed samples. 
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Figure 8: Effect of porosity on the compressive strength of 316L CF-HIPed samples. 
 
Figure 9: Effect of porosity on the Micro hardness of 316L HIPed samples. 
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3. Biocompatibility 
To evaluate the toxicity of the four CF-HIPed samples, a neutral red uptake assay was used. The 
Neutral red cytotoxicity assay is widely used in biomedical applications to quantify the viable 
cells in the culture. Only viable cells will be able to uptake the neutral red dye in their lysosomes 
via active transport 45. 
 
Figure 10: MC3T3 percent viability in the presence of CF-HIPed samples synthesised  using a 
particle size of  5 µm, 10 µm, 16 µm ,  50 µm , negative control (media only) and positive 
control (H2O2). Results are expressed as mean values of 3 independent experiments ±SD. ** 
p<0.01, *** p<0.001 and **** p<0.0001 as determined by one-way ANOVA and Tukey’s 
multiple comparison test using GraphPad Prism 7.03 
 
The cytotoxicity data is summarized in Figure 10. All the prepared CF-HIPed samples were 
found to have a minimal toxic effect on the MC3T3 cells. The neutral red cytotoxicity data 
showed that all CF-HIPed samples were biocompatible with significantly less toxic effect on the 
viability of the cells when compare to toxic agents such as hydrogen peroxide (p<0.0001). 
Nonetheless, one of the four formulations namely CF-HIPed samples of 5 µm had a significant 
effect on the viability of the cells compared to the negative control (Figure 11& Figure 12). 
Osteolysis or bone loss occurs when the balance between bone formation and bone resorption is 
affected. The decrease of peri-implant bone formation will be associated with osteolysis. In 
order to assess the peri-implant osteoblasts’ growth, an incucyte ZOOM® was used to visualize 
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the proliferation patterns of MC3T3 cells in the presence of the CF-HIPed implants.  
Both pore size and total porosity of bone implants are key factors in bone formation both in vivo 
and in vitro. It is believed that low porosity inhibits cell proliferation and forces cells to 
aggregate which stimulate osteogenesis. On the contrary, implants with large pores and high 
porosity content enhance bone ingrowth. The micro-CT data demonstrated that coarse particles 
formed highly porous structures with total porosity of 25.4% when particles of 50 µm were 
used. Seeding MC3T3 cells onto the stainless steel scaffolds showed a slow proliferation profile 
for CF-HIPed implants prepared with 5 µm particles. After 5 hours of seeding, less than 50% 
phase object confluence was achieved around the stainless steel implants. The confluence 
percentage increased to 57%, 67%  and 56% for CF-HIPed implants made of 10, 16 and 50 µm 
respectively. The highest confluence percentage was observed in CF-HIPed implants made of 
particle size of 16 µm followed by implants made of particle size of 50 µm after 24 hours of 
seeding.  
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 Figure 11: Growth of MC3T3 on CF-HIPed samples manufactured  using a particle size of  a) 5 
µm, b) 10 µm, c) 16 µm , d) 50 µm and in presence of e) media (negative control) and f) 
hydrogen peroxide (positive control). 
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 Figure 12: Images of MC3T3 growth at different time intervals on CF-HIPed samples 
manufactured using a particle size of  a) 5 µm, b) 10 µm, c) 16 µm , d) 50 µm. Images are 
representative of 3 independent experiments. 
0.5 h 2 h 
12 h 24 h 
0.5 h 2 h 
12 h 24 h 
(a) 5 µm (b) 10 µm 
0.5 h 2 h 
12 h 24 h 
(c) 16 µm 
0.5 h 2 h 
12 h 24 h 
(d) 50 µm 
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5. Discussion 
A cost effective CF-HIPing technology was successfully introduced to manufacture four 
different porous stainless steel 316L samples by using four different powder particle sizes. In all 
the prepared samples, CIPing and CF-HIPing process parameters (pressure, temperature, and 
hold time) were all kept constant. Therefore, the particle size was the only variable that affects 
the solid-state diffusion during CF-HIPing consolidation. This was supported by the 
microstructure and micro-CT imaging results as shown in Figure 4, Figure 5. In general, there 
was an increase in the porosity content, the pore size, and the interconnectivity between pores 
when the particle size increased. As shown in Figure 4, the porosity content of CF-HIPed 
samples prepared using particle size of 50 µm was the largest compared to the other three 
samples. Quantitative analysis of the porosity showed that the porosity content increased by 
24% from 1.4% to 25.4% with the increase of the mean powder particle size from 5 µm to 50 
µm. In addition, for all samples, the surface connected pores increased by increasing the particle 
size as shown in Figure 6.  
It could be noted that the high porosity contents, the large pore size and the irregular pores, 
which were associated with the increase of the particle size, caused the deterioration in the 
mechanical properties of the samples. This is in agreement with the research by Kurgan 46 and 
Dewidar 47 who concluded a significant decrease in the mechanical properties of stainless steel 
316L samples with the increase of porosity content. After analysing the mechanical properties, it 
can be noted that, samples prepared using powder particle size of 5 µm exhibits an increased 
Young's modulus (Figure 8 b), due the decreased porosity content. Young's modulus of 17–
30 GPa, compressive strength of 107-190 MPa, and hardness of 25-28 HV can be achieved 
using implants prepared by particle of sizes between 32-50 µm (Figure 7). The Young's modulus 
and compressive strength values would be in a close range to that of human bone 48. 
Furthermore, the high porosity content (17-25%) of the recommended implants would allow 
bone ingrowth, which could further stabilize the implants and would be favourable to avoid 
stress-shielding problems observed for solid bulk stainless steel implants 49, thus hence avoids 
implant loosening and promoting bone growth.  
Generally, metallic biomaterials possess a wide range of mechanical properties such as fracture 
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toughness, ductility, high strength, formability and resistance to corrosion 50. Nonetheless, 
metallic biomaterials devoid biological recognition on their surfaces, therefore, surface 
modification or surface coating are recommended to enhance biocompatibility. Besides, 
biomaterials of metallic origin can release toxic particles or ions leading to allergic and 
inflammatory reactions that cause loss of tissues. As discussed earlier, stainless steel has 
superior mechanical properties, nonetheless, it has lower resistance to corrosion compared to 
other implants; for instance titanium 51. In addition, stainless steel content of nickel and high 
potential of allergic reactions makes it less biocompatible 52. Around 80% or more of MC3T3 
cells were healthy and viable for all CF-HIPed samples (Figure 12). CF-HIPed samples had a 
minimal toxic effect on the osteoblasts. These results are in agreement  with the study conducted 
by Molders et al. 53, the study reported that some of the metal ions (Fe, Cr, Mo, Mn) released 
from the stainless steel can accumulate in the cells and disturb some cellular functions such as 
the bone morphogentic protein 2. Nonetheless, the study concluded that stainless steel samples 
used were biocompatible as it does not affect the growth of MC3T3-E1 cells as reflected by the 
Thiazolyl Blue assay (MTT assay). 
The pore size range of the four scaffolds was comparable as demonstrated by the micro-CT 
imaging and cross-sectional SEM micrographs. Nonetheless, the percentage total porosities 
were significantly different. The live cell analysis showed that increasing the total percentage 
porosity was associated with increasing the proliferation of the osteoblasts. Samples prepared 
using 5 µm particles had the lowest total porosity of 1.4% and were associated with a slow 
growth rate. Increasing the percentage porosity to 11% and 12.9% respectively, was associated 
with increased  proliferation of MC3T3 cells (Figure 12 b&c). The low porosity is believed to 
hinder the transport of nutrients and oxygen to the cells hence the lower proliferation in the 5 
µm implants as suggested by Takahashi et al. 54.  
On the other hand, high-density stainless steel could be achieved using particle size of 5 µm, 
which exhibited the best mechanical properties as compared to the other samples. The 
compressive strength of that samples was about 360 MPa which is similar to that of the bulk 
stainless steel 316L 44. The presence of the surface porosity as shown in Figure 6a has one 
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additional benefit. If CF-HIPing route is to be used for dense structures, with only limited 
machining (in the order of <500 µm), will be required to remove the porous surface layer. 
Therefore, they are applicable in biomedical devices with less load-bearing capacity or other 
applications such as aerospace and automotive fields where high mechanical properties are 
favourable. 
6. Conclusions 
This study shows that the proposed CF-HIPing route was efficient to control the porosity of 
stainless steel parts and proved to be well-suited cost effective route for biomedical implants. It 
was found that CF-HIPed stainless steel samples of particle size between 5 and 50 µm had a 
porosity level varying from 1.4% to 25.4%, respectively. Variation of the porosity was found to 
have an impact on the mechanical and biological properties of the samples. In this respect, 
decreasing the powder particle size resulted in an improvement of the Young’s modulus, 
compressive strength, and hardness of the CF-HIPed samples. By analysing the obtained 
properties and comparing them to human bone characteristics. It can be concluded that the 
proposed approach can be used to manufacture samples, which are appropriate for hard-tissue 
applications with Young’s moduli between 17 and 30 GPa and high proliferation. The porosity 
fraction for those samples was 16 to 25.4% and the mechanical properties were 107 to 190 GPa 
for compressive strength, and from 25 to 28 HV for micro-hardness. An implant with such 
characteristics would be suitable for osseointegration. Thus, stress shielding can be prevented as 
the mechanical properties of the proposed materials are similar to that of human bone and the 
tissue growth could take place through the high level of interconnected pores, however, in vivo 
trials should be the next step. It is anticipated that the proposed approach could reduce the 
number of revision surgery. Finally, it is also worth to emphasise that although the aim of this 
work was mainly to develop porous structures, the results highlight the possibility of using the 
CF-HIPing approach to create highly dense structures, which can only be achieved using 
canisters with fine particle size. This limits the degree of surface connectivity, leaving behind a 
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porous surface region of ~100 µm, which can be later machined or electrochemically etched to 
generate a fully dense surface.  
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